Page 61 - 2021
P. 61

POST GRADUATE DISSERTATIONS




 Sr.  Enrollment   Name   Dissertation/Project Title       Broad Area of
 No.  No.  Name of Student  Branch  of supervisor        Research/Project

 Faculty of Pharmacy (M.Phram)
 F F aculty of Pharmacy (M.Phram)
 aculty of Pharmacy (M.Phram)
 Formulation, Optimization and Evaluation of Ticagrelor      Formulation
 08  19024671008 Sankhala Raj Sanjay  P'ceutics  Patel G. K.
 Tablets with Improved Dissolution Profile                  Development

 Formulation, evaluation & optimization of fixed dose combination tablets
 Sejani Ravikumar   of dapagliflozin as a immediate release (IR) and metformin hcl as a   Formulation
 sustain release (SR) dosage form (B) to study listedness of adverse
 09  19024671009  P'ceutics  Patel R.P.  drug reactions from external sources with reference to originator’s
 Bharatbhai  prescribing information (pi) and summary of product characteristics   Development
 (SPC) using anti-hyperlipidemic drugs


 Shukla Maheka   Development and Characterization of Topical Drug   Formulation
 10  19024671010  P'ceutics  Patel R.P.
 Vipulkumar  Delivery System for the Treatment of Hyperpigmentation  Development



 Sojitra Saurabh   Formulation and Evaluation of Losartan Potassium and   Formulation
 11  19024671011  P'ceutics  Hinglagiya H.R.
 Rameshbhai  Hydrochlorothiazide as Bilayer Tablet          Development



 Vagdoda   Formulation and Evaluation of Midodrine Hydrochloride   Formulation
 12  19024671012  P'ceutics  Prajapati B.G.
 Sagar Kanjibhai  Extended Release Matrix Tablet            Development

 Process Validation of Piroxicam Dispersible Tablets Ip
 Doshi Janavi   and Development and Validation of Analytical Methods   Method validation
 13  19024611001  QA  Patel S.A.
 Shreyashkumar  for Simultaneous Estimation of Azelnidipine and   and Development
 Telmisartan in Synthetic Mixture
 Process Validation of Multiple Electrolyte and Dextrose

 14  19024611002  Parikh Kajol Samir  QA  Patel P.U.  Type Iii Injection IP and Development and Validation of   Method validation
 Analytical Methods for Emtricitabine and Tenofovir
                                                          and Development
 Alafenamide in Synthetic Mixture



 30
   56   57   58   59   60   61   62   63   64   65   66